Latest Acromegaly Stories
-- Acromegaly is an endocrine disorder caused by elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels(1) -- Signifor LAR, a next-generation somatostatin
ReportsnReports.com adds EpiCast Report Acromegaly and Gigantism Epidemiology Forecast to 2023 to its store.
- Primary efficacy endpoint met with a statistically significant reduction of sIGF-I levels of 26% at the 400mg/week dose (P
-Primary efficacy results on track to be received by end of August 2014 TOORAK, Australia, July 29, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP") is pleased to report
Acromegaly, an endocrine disorder resulting from elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels, is associated with high mortality(1,2) EAST HANOVER, N.J., May
- 24 patients now recruited into the trial TOORAK, Australia, March 21, 2014 /PRNewswire/ -- Antisense Therapeutics Limited ("ANP") is pleased to report that 24 acromegalic
SAN FRANCISCO, Jan.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.